The content on this site is intended for healthcare professionals only
Prof Richard Sullivan (Kings College London, London, UK) and Dr André Ilbawi (Technical Officer Cancer Control, WHO) discuss the policies regarding ease of access to cancer medicines.
Initially, Dr Ilbawi talks about the issues around the policy aspect of access to cancer medicine and what has changed so far in these initiatives.
He further discusses how the world policy regarding access to essential cancer medicine has adapted to the rapid changes in the cancer treatment world and what infrastructure is available to accommodate the new drugs and trials present.
They discuss the limiting factors that WHO faces in increasing access to cancer medicine and how they can be overcome.
They conclude by talking about the future of cancer care and how accessibility to essential cancer medicine can be further improved.
Tele-mentoring: Impact of project ECHO
ASCO's strategic plan for cancer care in LMICs
Introducing oncology to undergraduate medical and allied health sciences students
OncoAlert Round Up for September 15-21, 2023
Decision making in paediatric oncology
Advocacy that impacts patients outcomes in Africa - challenges and opportunities
Choosing cancer medicines wisely in Africa
The cancer access partnership
The Max foundation: Its mission and contribution to increasing access to cancer medicine
